heavy periods / extremely heavy bleeding during period; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory agency (ra). regulatory number: gb-mhra-webcovid-202202140847075400-7nbiz (ra). other case identifier(s): gb-mhra-adr 26600065 (ra). a patient (no qualifiers provided) received bnt162b2 (comirnaty), administration date 28jan2022 (batch/lot number: unknown) as dose 2, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. vaccination history included: covid 19 vaccine (dose 1; manufacturer unknown), for covid-19 immunisation. the patient did not have symptoms associated with covid-19 and was not enrolled in clinical trial. the following information was reported: heavy menstrual bleeding (medically significant) with onset 13feb2022, outcome "not recovered", described as "heavy periods / extremely heavy bleeding during period". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: no - negative covid-19 test. the patient had not been tested positive for covid-19 since having the vaccine. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

test name: covid-19 virus test; result unstructured data: test result:no - negative covid-19 test

na

na